跳转至内容
Merck
CN

66540580

BIONi037-A

Human iPS Cell Line

登录 查看组织和合同定价。

选择尺寸


关于此项目

UNSPSC Code:
41106509
Biological source:
human dermis (fibroblast)
Relevant disease(s):
none
Reprogramming method:
episomal
Gender:
female
Growth mode:
adherent (pluripotent)
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

biological source

human dermis (fibroblast)

reprogramming method

episomal

description

age (75-79)

manufacturer/tradename

EBiSC

gender

female

growth mode

adherent (pluripotent)

technique(s)

cell culture | stem cell: suitable

relevant disease(s)

none

shipped in

dry ice

storage temp.

−196°C

General description

Induced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.

The EBiSC stem cell bank is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimer′s Disease, Parkinson′s Disease, Dementia, Motor Neuron Disease (ALS) - and Huntington′s Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.

Biochem/physiol Actions

Depositor
Bioneer
Derivation
Primary cell type: Fibroblast of dermis
Location of primary tissue procurement: Zone of skin
Tissue collection year: 2010
Passage number reprogrammed: 18
Reprogramming method
Vector type: Non-integrating
Vector: Episomal
Gene list:
KLF4
Lin28
MYC
POU5F1
SOX2
Is the reprogramming vector detectable: No
Merthods used: pcr

Xeno free conditions: no
Derived under gmp: no
Available as clinical grade: no

Characterization

Analysis of Undifferentiated Cells
Morphology:
07-25-2017 16423 apoe 33 .tif
Microbiology / Virus Screening
HIV 1: Negative
HIV 2: Negative
Hepatitis B: Negative
Hepatitis C: Negative
Mycoplasma: Negative

Genotyping
Karyotyping
Passage number: 25
Cell line karyotype: 46 XY
Karyotyping method: G-Banding
Image / Result

Preparation Note

Surface coating: Matrigel®/Geltrex®
Passage method: Enzyme-free cell dissociation / EDTA
O2 concentration: 18%
CO2 concentration: 5%
Culture medium: Essential E8®
Passage Number banked (pre-EBiSC): 18
No. Vials banked (pre-EBiSC): 30

Other Notes

Note: EAUA and CLIP must be completed before order fulfillment

Legal Information

E8 is a registered trademark of WIsconsin Alumni Research Foundation non-stock Corporation
EBiSC is a trademark of Fraunhofer-Gesellschaft
GELTREX is a registered trademark of Life Technologies Corporation
Matrigel is a registered trademark of Corning, Inc.

存储类别

10 - Combustible liquids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

高风险级别生物产品--人源产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持